Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Biosyent Inc V.RX

Alternate Symbol(s):  BIOYF

Healthcare
BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing biologically and health friendly non-chemical insecticides. Its products include Combogesic, Cathejell, FeraMAX Pd Therapeutic 150, FeraMAX Pd Maintenance 45, FeraMAX Pd Powder 15, Gelclair, Inofolic, Proktis-M, RepaGyn, and Tibella. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. Cathejell combines sterile gel and 2% lidocaine jelly in a collapsible syringe that is ready to use. FeraMAX Pd Therapeutic 150 is an oral hematinic that helps the body form red blood cells and is indicated for the treatment of iron deficiency anemia.


TSXV:RX - Post by User

Biosyent Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by bthoughtson Sep 30, 2014 3:14pm
137 Views
Post# 22984601

RE:RE:RE:RE:Thanks

RE:RE:RE:RE:Thanks

Thanks lscfa and westcoast1000 for your reply and recommednations
 

I did a brief check on both DND and MSL

DND - very solid

MSL - the ceo recently resigned and there was a major price drop, this could be a great opportunity yet I'm worried, from past experience when people left or resigned there was usually issues with the company, the price and potential on this looks good

Right now i've narrowed it down to DND, MSL, RX and CXR

DND - is very solid

MSL - possible great entry point at this time with the recent drop, but don't know to wait and see or to take the risk and jump in

RX - great past performance and management team so far, but feels there quite a bit volitlity

CXR - RBC just recently released a new price target and I feel momentum will be building for this, wish got in at lower price point

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities